Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Porter

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Annals of the New York Academy of Sciences|December 13, 2005
Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical useJ B Porter, R Rafique, S Srichairatanakool, et al.
British Journal of Haematology|December 1, 1995
The metabolites of nitric oxide in sickle-cell diseaseD C Rees, P Cervi, D Grimwade, et al.
Blood|November 15, 1991
Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded miceJ B Porter, K P Hoyes, R D Abeysinghe, et al.
Blood|November 1, 1988
Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constantJ B Porter, M Gyparaki, L C Burke, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 4, 1998
Endothelial activation in patients with chronic venous diseaseM Saharay, D A Shields, S N Georgiannos, et al.
British Journal of Cancer|November 21, 1998
Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agentsA Curnow, B W McIlroy, M J Postle-Hacon, et al.
The Journal of Biological Chemistry|April 5, 1996
The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelatorsR D Abeysinghe, P J Roberts, C E Cooper, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 18, 2011
Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoidsC Thephinlap, C Phisalaphong, N Lailerd, et al.
The Journal of Biological Chemistry|October 17, 2001
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductaseR Kayyali, J B Porter, Z D Liu, et al.
JAMA|September 24, 1982
Drug monitoring of surgical patientsD A Danielson, J B Porter, B J Dinan, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Annals of the New York Academy of Sciences|December 13, 2005
Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical useJ B Porter, R Rafique, S Srichairatanakool, et al.
British Journal of Haematology|December 1, 1995
The metabolites of nitric oxide in sickle-cell diseaseD C Rees, P Cervi, D Grimwade, et al.
Blood|November 15, 1991
Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded miceJ B Porter, K P Hoyes, R D Abeysinghe, et al.
Blood|November 1, 1988
Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constantJ B Porter, M Gyparaki, L C Burke, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 4, 1998
Endothelial activation in patients with chronic venous diseaseM Saharay, D A Shields, S N Georgiannos, et al.
British Journal of Cancer|November 21, 1998
Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agentsA Curnow, B W McIlroy, M J Postle-Hacon, et al.
The Journal of Biological Chemistry|April 5, 1996
The environment of the lipoxygenase iron binding site explored with novel hydroxypyridinone iron chelatorsR D Abeysinghe, P J Roberts, C E Cooper, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 18, 2011
Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoidsC Thephinlap, C Phisalaphong, N Lailerd, et al.
The Journal of Biological Chemistry|October 17, 2001
Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductaseR Kayyali, J B Porter, Z D Liu, et al.
JAMA|September 24, 1982
Drug monitoring of surgical patientsD A Danielson, J B Porter, B J Dinan, et al.
Pageof 10